Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Drug experiment blocks radiation damage
ap ^ | 4/10/08 | By LAURAN NEERGAARD, AP Medical Writer

Posted on 04/10/2008 3:31:15 PM PDT by Flavius

WASHINGTON - Scientists mimicked one of cancer's sneaky tricks to create a drug that promises to prevent a serious side effect of cancer treatment — radiation damage — or offer an antidote during a nuclear emergency.

(Excerpt) Read more at news.yahoo.com ...


TOPICS: News/Current Events
KEYWORDS: iran; war

1 posted on 04/10/2008 3:31:15 PM PDT by Flavius
[ Post Reply | Private Reply | View Replies]

To: Flavius

“I am Legend”


2 posted on 04/10/2008 3:31:46 PM PDT by Jeff Head (Freedom is not free...never has been, never will be. (www.dragonsfuryseries.com))
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius

That’s interesting!


3 posted on 04/10/2008 3:39:44 PM PDT by DB
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius

Uh oh, the anti-cell phone alarmists are not going to like this one bit........


4 posted on 04/10/2008 4:06:37 PM PDT by raptor29
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius
For those that wonder why this is a big deal

The observations suggest a judgment that 4.5 Gy (450 rad) absorbed dose in the bone marrow for energetic and therefore penetrating gamma rays giving reasonably uniform irradiation of the marrow could be regarded as the LD50 in circumstances where those irradiated were protected from thermal radiation and blast damage and from neutrons and beta rays.

(Cue Black Sabbath - War Dogs)

For a discussion of the whole "Gy" thing, see this: http://en.wikipedia.org/wiki/Nuclear_fallout

A dose of 5.3 Gy to 8.3 Gy is considered lethal but not immediately incapacitating. Personnel exposed to this amount of radiation will have their performance degraded within 2 to 3 hours, depending on how physically demanding the tasks they must perform are, and will remain in this disabled state at least 2 days.

However, at that point they will experience a recovery period and be effective at performing non-demanding tasks for about 6 days, after which they will relapse for about 4 weeks. At this time they will begin exhibiting symptoms of radiation poisoning of sufficient severity to render them totally ineffective.

Death follows at approximately 6 weeks after exposure, although results may vary.

The drug has no effect on other dangers, radioactive Iodine 141 for example....but is good news.

5 posted on 04/10/2008 4:14:20 PM PDT by ASOC (Training Storungen werden auf Papier notiert. Taktische Storungen werden im Stein geatzt. Gen Rommel)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Robert A. Cook, PE; neverdem; shrinkermd; snarks_when_bored; Judith Anne; Smokin' Joe
Like, *PING*, folks.

One question -- will this lead to iatrogenic spread of smaller tumors (in the GI and marrow) where the drug stops the apoptosis of other tumors the body *would* have caught?

Cheers!

6 posted on 04/10/2008 6:58:56 PM PDT by grey_whiskers (The opinions are solely those of the author and are subject to change without notice.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

If you don't mind answering me, can you access the abstract, or do you you have to register?

7 posted on 04/10/2008 7:32:10 PM PDT by neverdem (I'm praying for a Divine Intervention.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius

8 posted on 04/10/2008 7:44:24 PM PDT by HangnJudge
[ Post Reply | Private Reply | To 1 | View Replies]

To: Flavius

http://www.cbiolabs.com/

On primate studies,
no evidence of increased carcinogenesis has been seen

Rhesus monkeys were irradiated with 6.5 Gy of total body irradiation and injected intramuscularly with either a single dose of Protectan cblb502 or a placebo, one hour after irradiation. No supportive therapy was applied. The animals were observed for 40 days. cblb502 enabled survival of 70% of the animals in the protected group, versus the control group, in which 20% of the animals survived. In addition, gross pathology results showed that the majority of control animals displayed severe damage to the GI tract, while the cblb502 treated animals did not. This data demonstrates cblb502’s capacity as a mitigator of gastrointestinal radiation-induced injury.

Dr. Gudkov commented, “The level of protection observed in this study is very impressive and we are gratified to see that it is as high as the level achieved when Protectan cblb502 is administrated one hour prior to irradiation. This confirms our previously achieved results in mitigation of radiation damage in rodents. cblb502 is the first compound to provide protection from both gastrointestinal and hematopoietic radiation-induced damage when administrated before or after irradiation


9 posted on 04/10/2008 7:56:07 PM PDT by HangnJudge
[ Post Reply | Private Reply | To 1 | View Replies]

To: grey_whiskers
One question -- will this lead to iatrogenic spread of smaller tumors (in the GI and marrow) where the drug stops the apoptosis of other tumors the body *would* have caught?

I don't know. Let me know if you can access this link. I only read the last page of the text, page 4.

Telomeres, Telomerase, and Tumorigenesis -- A Review

I can FReepmail it otherwise.

10 posted on 04/10/2008 8:04:52 PM PDT by neverdem (I'm praying for a Divine Intervention.)
[ Post Reply | Private Reply | To 6 | View Replies]

To: ASOC
The drug has no effect on other dangers,
radioactive Iodine 141 for example....


Iodine-131? Half Life 8.06 Days and is a common fission byproduct
Iodine 141 has a half life of ~ 430 ms
11 posted on 04/10/2008 8:05:37 PM PDT by HangnJudge
[ Post Reply | Private Reply | To 5 | View Replies]

To: HangnJudge
My bad, it is 131.

Wife is a Downwinder, has a bum thyroid due to this “short lived product”. So do her brothers & sisters.

12 posted on 04/10/2008 8:43:58 PM PDT by ASOC (Training Storungen werden auf Papier notiert. Taktische Storungen werden im Stein geatzt. Gen Rommel)
[ Post Reply | Private Reply | To 11 | View Replies]

To: neverdem
Please FReepmail, it is asking me to register.

Thanks!

13 posted on 04/10/2008 8:47:56 PM PDT by grey_whiskers (The opinions are solely those of the author and are subject to change without notice.)
[ Post Reply | Private Reply | To 10 | View Replies]

To: grey_whiskers
One question -- will this lead to iatrogenic spread of smaller tumors (in the GI and marrow) where the drug stops the apoptosis of other tumors the body *would* have caught?

Dang, g_w, that was exactly the question I wanted to ask...

14 posted on 04/11/2008 8:31:41 AM PDT by snarks_when_bored
[ Post Reply | Private Reply | To 6 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson